Pharmaceutical Contract Research And Manufacturing Market Size to grow by USD 141.3 billion between 2024-2028
The Pharmaceutical Contract Research And Manufacturing Market is segmented by Service (CMO and CRO), End-user (Big pharmaceuticals, Small and medium-sized pharmaceuticals, and Generic pharmaceuticals), and Geography (North America, Asia, Europe, and Rest of World (ROW)). As per the Global Forecast research report 2024-2028 published by Technavio, the market size is estimated to grow by USD 141.3 billion, at a CAGR of 10.87% during the forecast period. There are several companies that are contributing to the market as per this report. Increasing number of US FDA approved manufacturing facilities .
By Service, the CMO segment is projected to dominate the market size in 2024
The Contract Research and Manufacturing Organizations (CMO) segment dominates the global pharmaceutical CRAM market, accounting for the largest share due to the increasing outsourcing trends by pharmaceutical vendors and biotech companies for manufacturing their drugs and healthcare products on a contract basis. Advancements in medical sciences, particularly in the development of specialty medicines and emerging technologies like nanotechnology and stem cell research, are driving the demand for more complex manufacturing processes. These processes require extended resource deployments, leading pharmaceutical giants such as Pfizer, Johnson & Johnson, and GlaxoSmithKline to outsource their manufacturing activities to CMOs, thereby optimizing their in-house resources and focusing on their core competencies.
For insights on company offerings- Request a sample report!
By End-user, Big pharmaceuticals segment is expected to hold the largest market size for the year 2024
In the pharmaceutical industry, large publicly traded pharmaceutical companies, often referred to as "big pharma," play a pivotal role. These entities, including Pfizer Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Sanofi SA (France), Johnson & Johnson (US), Merck & Co. (US), and Novartis AG (Switzerland), typically possess extensive resources and capabilities that extend beyond medical devices. By outsourcing to Contract Research and Manufacturing Organizations (CMOs), these pharmaceutical giants can augment their technical resources without incurring additional overhead. Over the past 25 years, CMOs have grown increasingly significant within the pharmaceutical sector.
Why is North America forecasted to hold the largest regional market size in 2024?
The Pharmaceutical Contract Research and Manufacturing (CRO/CMO) market plays a pivotal role in the drug development process, providing outsourced services for research, development, and manufacturing of pharmaceuticals. This sector offers cost-effective solutions, enhancing efficiency and reducing time-to-market for pharmaceutical companies. Key services include clinical trial management, formulation development, and commercial manufacturing. The market's growth is driven by increasing R&D expenditures, regulatory compliance, and a shift towards outsourcing.
To access the valuable insights - Download the Free Sample Report
Research Analysis Overview
The Pharmaceutical Contract Research and Manufacturing (CRAMS) market encompasses the production of active pharmaceutical ingredients (APIs) and drug formulations for oral solids, including low potent APIs derived from both originator and generic sources. This market caters to the needs of drug candidates in various stages of development, from small molecule drugs to biosimilars and biologics. CRAMS providers offer specialized services such as continuous manufacturing, advanced manufacturing technologies, and quality control to ensure regulatory compliance and cost-effective manufacturing. These services are crucial during drug discovery, clinical trials, and regulatory approval processes. Moreover, the CRAMS market leverages advanced technologies like artificial intelligence to optimize manufacturing processes, improve efficiency, and reduce costs. Bioprocess outsourcing is also a significant trend, with companies increasingly relying on CRAMS providers for the production of complex biologics. Route scouting services and drug development are other key areas where CRAMS providers add value to the pharmaceutical industry. The market caters to both large and small pharmaceutical companies, providing cost-effective solutions for manufacturing and regulatory compliance. In summary, the Pharmaceutical CRAMS market plays a vital role in bringing new drugs to market, from discovery to commercialization.
Market Research Overview
The pharmaceutical market encompasses businesses involved in the research and development (R&D) or manufacturing of various pharmaceutical products, including generic drugs, non-generic drugs, and veterinary drugs. According to Technavio's market analysis, the global healthcare industry is determined by the consolidated revenue generated by providers and manufacturers of medical equipment, pharmaceuticals, biotechnology, life sciences tools, and services. The expansion of the pharmaceuticals market will be fueled by several key factors, including the increasing global population aging. By 2050, approximately one-quarter of the US population and Europe's population ratio is projected to reach 60 years or above. - The Pharmaceutical Contract Research And Manufacturing Market is experiencing significant growth, fueled by the . Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
